Alzheimers disease drug development pipeline: 2021
Baseline WOMAC pain score: approximately 6 out of 20 Reduction in active treatment arms: approximately 4.5 points , representing a ~76% decrease from baseline Complete freedom from knee pain at week 68: reported by roughly 1 in 8 patients (12.5%) receiving retatrutide, compared to just 4.2% in the placebo group A 76% reduction in pain scores is extraordinary approaching the range typically seen after total knee replacement surgery
This aligns with findings from the STEP-2 25 and STEP-6 studies 25 , which reported higher incidences of psychiatric events with higher doses of semaglutide compared to placebo
33,34 Because GSH is vital in detoxification and cell physiology, its depletion has been speculated to represent an important contributing factor of liver injury, and enhanced morbidity in patients with liver injury
By slowing digestion and influencing the brains appetite centers, semaglutide helps patients feel full earlier and stay full longer, leading to reduced food intake and meaningful weight loss
Age, sex, nutritional status, adiposity, dietary preferences, habits such as smoking, use of concurrent medications, physiologic states such as pregnancy, pathologic states such as liver disease, and others can affect one or more of the 3 processes listed above, thereby influencing the half-life of psychotropic and other drugs
